O novo modelo de alta eficiência, orientado a dados da BCG, permite que os representantes de vendas ofereçam aos prestadores de cuidados de saúde uma experiência de vendas personalizada-sem um tremendo valor para os acionistas.
EDUCAÇÃO
- PhD, estratégia de negócios e análise de consumidores, Universidade Técnica de Munique
- Mestrado, Economics e Illinois, Urbana de Kiel/Universidad Autónoma de Madrid/University of Illinois em Urbana. Prática no Boston Consulting Group. Ele trabalha em uma ampla gama de tópicos com seus clientes nos campos de biofarma, saúde do consumidor e saúde animal. Friedemann lidera o trabalho da empresa em modelos de engajamento de clientes para clientes de biopharma globalmente, bem como os negócios de saúde e saúde animal do consumidor. Ele é particularmente experiente em estratégia e transformações em larga escala, transformações digitais e tópicos relacionados a marketing e vendas, com foco no uso de dados e análises para impulsionar estratégias de entrada no mercado. Ele também trabalha com seus clientes em estratégias de Biotech Venture, saúde digital e novas tecnologias.
Friedemann Wolf is a core member of the Health Care practice at Boston Consulting Group. He works on a broad range of topics with his clients in the fields of biopharma, consumer health, and animal health. Friedemann leads the firm’s work in customer engagement models for biopharma clients globally, as well as the consumer health and animal health businesses. He is particularly experienced in strategy and large-scale transformations, digital transformations, and marketing and sales related topics, with a focus on using data and analytics to drive go-to-market strategies. He also works with his clients on biotech venturing, digital health, and new technology strategies.
In his recent engagements, Friedemann led the go-to-market strategy transformation and next generation customer engagement model for one of his global pharma clients, and supported the development of digital health solutions for a specialty pharma business. He also supported the portfolio strategy and organizational transformation for a leading consumer health company, with a focus on accelerating the digital transformation. In addition, he worked with several biopharma companies on market launch and competitive strategies, as well as venturing and incubating new businesses.
